Categories: Business

Fellaz Launches Decentralized Entertainment Protocol Stack | Massive Giveaway Live: Win $3,000 Beta Access + Over 2,000 USDT

SINGAPORE, July 4, 2025 /PRNewswire/ — Web3 entertainment protocol Fellaz has officially launched its decentralized entertainment stack, composed of three core protocols: Fellaz ID, Fellaz RWA, and Fellaz Creator. The initiative aims to disrupt the traditional entertainment industry by enabling fans and creators to own, monetize, and govern entertainment content directly.

- Advertisement -

The Fellaz ecosystem addresses the limitations of legacy platforms by:
 – Tokenizing fandom via Fellaz ID and soulbound tokens (SBTs), rewarding verified fan engagement
 – Turning IP into liquid, tradable assets through Fellaz RWA, enabling fans to invest in music, film, and merchandise
 – Empowering creators with Fellaz Creator, a decentralized toolkit for monetization, rights management, and DAO governance

- Advertisement -

Importantly, Fellaz is backed by Innocus Global Group, a real-world entertainment conglomerate, ensuring immediate access to live IP, artists, and cultural assets from day one. Its native utility token $FLZ will serve as the fuel for staking, access control, governance, and rewards across the ecosystem.

- Advertisement -

Fellaz is also running a massive giveaway campaign, offering a chance to win $3,000 Beta Test Access and over 2,000 USDT in airdrop rewards.
 Follow @FellazXYZ and join now:https://x.com/FellazXYZ/status/1940040367438782865

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/fellaz-launches-decentralized-entertainment-protocol-stack–massive-giveaway-live-win-3-000-beta-access–over-2-000-usdt-302498284.html

- Advertisement -
PRNW Agency

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

2 days ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

1 week ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

2 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago